Evidence map›Paper›PMID 34986150›Full record

ArticlePloS one

Poly-glutamine-dependent self-association as a potential mechanism for regulation of androgen receptor activity.

Carlos M Roggero, Victoria Esser, Lingling Duan, Allyson M Rice, Shihong Ma, Ganesh V Raj, Michael K Rosen, Zhi-Ping Liu, Josep Rizo

Open access · goldAbstract read
In one paragraph

Article in PloS one. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Carlos M RoggeroDepartment of Biophysics, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
Victoria EsserDepartment of Biophysics, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
Lingling DuanDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
Allyson M RiceDepartment of Biophysics, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
Shihong MaDepartment of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
Ganesh V RajDepartment of Urology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
Michael K RosenDepartment of Biophysics, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
Zhi-Ping LiuDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
Josep RizoDepartment of Biophysics, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.ORCID https://orcid.org/0000-0003-1773-8311
The University of Texas Southwestern Medical Center · USHoward Hughes Medical Institute · US

Funding

Targeting KDM4B, a novel alternative splicing regulator, in castration-resistant prostate cancer (CRPC)R01CA215063 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI HSIEH, JER-TSONG, LIU, ZHI-PING · 2018 to 2022
$1.9M
NCI NIH HHS R01 CA215063
6 · The paper itself

Abstract

The androgen receptor (AR) plays a central role in prostate cancer. Development of castration resistant prostate cancer (CRPC) requires androgen-independent activation of AR, which involves its large N-terminal domain (NTD) and entails extensive epigenetic changes depending in part on histone lysine demethylases (KDMs) that interact with AR. The AR-NTD is rich in low-complexity sequences, including a polyQ repeat. Longer polyQ sequences were reported to decrease transcriptional activity and to protect against prostate cancer, although they can lead to muscular atrophy. However, the molecular mechanisms underlying these observations are unclear. Using NMR spectroscopy, here we identify weak interactions between the AR-NTD and the KDM4A catalytic domain, and between the AR ligand-binding domain and a central KDM4A region that also contains low-complexity sequences. We also show that the AR-NTD can undergo liquid-liquid phase separation in vitro, with longer polyQ sequences phase separating more readily. Moreover, longer polyQ sequences hinder nuclear localization in the absence of hormone and increase the propensity for formation of AR-containing puncta in the nucleus of cells treated with dihydrotestosterone. These results lead us to hypothesize that polyQ-dependent liquid-liquid phase separation may provide a mechanism to decrease the transcriptional activity of AR, potentially opening new opportunities to design effective therapies against CRPC and muscular atrophy.

Indexed as

AndrogensCell Line, TumorCell NucleusGene ExpressionGene Expression Regulation, NeoplasticGlutamineHumansMalePeptidesProstatic NeoplasmsProstatic Neoplasms, Castration-ResistantProtein DomainsReceptors, AndrogenSignal TransductionTranscriptional ActivationAndrogensAR protein, humanGlutaminePeptidespolyglutamineReceptors, Androgen

Identifiers

PMID34986150
PMCPMC8730435
OpenAlexW4225726015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.